We selected several cancers with the most obvious expression differences between tumor tissues and normal adjacent tissues (breast, pancreatic, colorectal, esophageal, gastric, and lung cancers) and explored the critical role of YAP1 in patient outcomes. This evidence concerns the gene YAP1 and lung cancer.